Special Issue: Covid-19 and Drug/Vaccine Discovery

American Journal of Pharmacology and Pharmacotherapeutics is pleased to announce Special issue on “Covid-19 and Drug/Vaccine Discovery”.

Researchers must make sure that they are studying the most up-to-date version of the virus. Also, they need to be able to grow the virus, which may thrive in host organisms but is fragile outside of them, in cell culture. In addition, if they can establish a helpful animal model, researchers will use the model to understand the viral mechanisms before developing the vaccine.

Finally, strong international coordination and cooperation between vaccine developers, regulators, policymakers, funders, public health bodies and governments will be needed to ensure that promising late-stage vaccine candidates can be manufactured in sufficient quantities and equitably supplied to all affected areas, particularly low-resource regions.

With the same purpose our Journal “American Journal of Pharmacology and Pharmacotherapeutics” is announcing Special issue Call for paper on “Covid-19 and Drug/Vaccine Discovery”. We welcome both solicited and unsolicited submissions that will contribute to this special issue.

Submission Process 

  • Special issue articles can include both original unpublished research articles and review articles related to the specific theme
  • Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
  • All the articles in special issues should strictly adhere to journal style and formatting.
  • Each special issue can be created with 5-7 articles.
  • All accepted manuscripts can be submitted online via https://www.imedpub.com/submissions/american-pharmacology-pharmacotherapeutics.html or through an email id to editor@imedpub.com
  • Submission should be accompanied by a cover letter with reference to the concerned special issue theme.

Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.imedpub.com/pharmacology-and-pharmacotherapeutics/author-guidelines.php